Exelixis, Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
EXEL Nasdaq 8731 http://www.exelixis.com 23.09 Stock Up +1.40

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Exelixis, Inc.

Exelixis tops Street 4Q forecasts - Feb 27th, 2017 3:18 pm
Exelixis tops Street 4Q forecasts - Feb 27th, 2017 3:18 pm
6:59 am Exelixis and Bristol-Myers Squibb (BMY) enter into clinical development collaboration to evaluate CABOMETYX with Opdivo - Feb 27th, 2017 4:59 am